| ATC code G: Genito-urinary system and sex hormones | 
|---|
| 
 | 
| ATCvet only | 
| 
 | 
| Other ATC codes | 
ATC code G Genito-urinary system and sex hormones is a section of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3][4]
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QG.[5] ATCvet codes without corresponding human ATC codes are cited with the leading Q in the following list.
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
References
- ↑ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
- ↑ World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
- ↑ "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
- ↑ "ATC/DDD Index 2022: code G". WHO Collaborating Centre for Drug Statistics Methodology.
- ↑ "ATCvet Index 2022: code QG". WHO Collaborating Centre for Drug Statistics Methodology.
| Major chemical drug groups – based upon the Anatomical Therapeutic Chemical Classification System | |
|---|---|
| gastrointestinal tract / metabolism (A) | |
| blood and blood forming organs (B) | |
| cardiovascular system (C) | |
| skin (D) | |
| genitourinary system (G) | |
| endocrine system (H) | |
| infections and infestations (J, P, QI) | |
| malignant disease (L01–L02) | |
| immune disease (L03–L04) | |
| muscles, bones, and joints (M) | |
| brain and nervous system (N) | 
 | 
| respiratory system (R) | |
| sensory organs (S) | |
| other ATC (V) | |
| 
 | |
| Antibiotics | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Arsenic compounds | |||||||||
| Quinoline derivatives | |||||||||
| Organic acids | |||||||||
| Sulfonamides | |||||||||
| Antifungals | 
 | ||||||||
| Other | |||||||||
| Cervical ripening | 
 | ||||
|---|---|---|---|---|---|
| Contraction induction | |||||
| 
 | |||||
| Comparison | |||||
|---|---|---|---|---|---|
| Behavioral | 
 | ||||
| Barrier and / or spermicidal | |||||
| Hormonal (formulations) | 
 | ||||
| Anti-estrogen | 
 | ||||
| Post-intercourse | |||||
| Intrauterine device | |||||
| Sterilization | 
 | ||||
| Experimental | |||||
| Long-acting reversible contraception (LARC) | |||||
| Tocolytics/labor repressants (G02CA) | |
|---|---|
| β2 adrenoreceptor agonists | |
| Oxytocin antagonists | |
| NSAIDs | |
| Calcium channel blockers | |
| Myosin inhibitors | |
| Prolactin inhibitors | |
|---|---|
| Anti-inflammatory products for vaginal administration | |
| Estrogens | 
 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Antiestrogens | 
 | ||||||||
| 
 
 | |||||||||
| Progestogens (and progestins) | 
 | ||||
|---|---|---|---|---|---|
| Antiprogestogens | 
 | ||||
| 
 
 | |||||
| GnRH modulators (incl. analogues) | 
 | ||||
|---|---|---|---|---|---|
| Gonadotropins | 
 | ||||
| Others (indirect) | 
 | ||||
| 
 
 | |||||
| Urologicals, including antispasmodics (G04B) | |
|---|---|
| Acidifiers | |
| Urinary antispasmodics (primarily antimuscarinics) | |
| Other urologicals | |
| For erectile dysfunction | 
 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| For premature ejaculation | 
 | ||||||||||||
| 
 | |||||||||||||
    This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

